![](https://cme.uchicago.edu/sites/default/files/styles/course_image/public/Cancer-cell.jpg?itok=djhUU3wx)
Annual Updates from ASH 2018: Practice Changing Abstracts
Target Audience
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Discuss how comprehension of biology of leukemias has influenced treatment approaches;
- Describe next generation improvements in CAR T-cell therapies that can improve patient outcomes;
- Identify methods for integrating therapeutic advances into practice to improve current myeloma patient care;
- List current best practice in first and second line therapies for lymphoid malignancies;
- Name new technologies for the treatment of hemophilia;
- Analyze how new scientific insights are informing diagnosis and treatment of myelodysplastic/myeloproliferative neoplasms.
- 3.75 AMA PRA Category 1 Credit™
- 3.75 Participation
Agenda subject to change.
![](https://cme.uchicago.edu/sites/default/files/styles/hotel_photo/public/GleacherS.jpg?itok=cttcjG3x)
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Polly Rossi via e-mail via at polly@meetingachievements.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
COURSE DIRECTOR
COURSE FACULTY
Associate Professor of Medicine
University of Chicago
Professor of Medicine
University of Chicago
Professor of Medicine
University of Chicago
Associate Professor of Medicine
University of Chicago
Assistant Professor of Medicine
University of Chicago
Professor of Medicine
University of Pennsylvania
Elwood v. Jensen Professor in Medicine
University of Chicago
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
CLAIMING CREDIT: Enter the access code to unlock the credit claiming process.